1Al-Lamki RS, Wang J, Thiru S, et al. Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants[J] . Am J Pathol, 2003, 163 (2):401-411
2Kiyoshi M, Edward E. Tumor necrosis factor receptor 1 is an ATPase by silencer of death domain [ J ]. Mol Cell Biol, 2002, 22(8): 2536-2543.
4Jiang Y, Woronicz JD, Goeddel DV, et al. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains [ J ].Science, 1999, 283 (5401): 543-546.
5Takada H, Chen NJ, Mirtsos C, et al. Role of SODD in regulated of tumor necrosis factor responses [ J ]. Mol Cell Biol, 2003, 23(11): 4026-4033.
6Harrington JR. SODD-silencer of death domains[ J]. Stem Cells,2000, 18(5): 388-389.
7Endres R, Hacker G, Broseh I, et al. Apparently normal tumor necrosis factor receptor l signaling in the absence of silencer of death domains[ J], Mol Cell Biol, 2003, 23 (18): 6609-6617.
8Zhang L, Shimizu S, Tsujimoto Y. Two distinct Fas-activated signaling pathways revealed by an anti-tumor drug [ J ]. Oncogene,2005, 24(18): 2954-2962.
9Willis AE. Ali's well that ends well: Translational control and cell death[J]. Cell Death Differ, 2005, 12(6): 533.
10Eichholtz-wirth H, fritz E, Wolz L. Over expression of the "silencer of death domain", SODD/BAG-4, modulates both TNFR1- and CD95-dependent cell death pathways[ J]. Cancer Lett, 2003, 194(1): 81-89.
3Bazzoni F,Beutler B. The tumor necrosis factor ligand and receptor families [ J ]. N Engl J Med, 1996,334 ( 26 ) : 1717 - 1725.
4Kolb WP, Granger GA. Lymphocyte in vitro cytotoxlcity: character- ization of human lymphotoxin[ J]. Proc Natl Acad Sci USA, 1968, 61(4) :1250 - 1255.
5Carswell EA, Old LG,Kassel RL, et al. An endotoxin-induced ser- um factor that causes necrosis of tumors [ J ]. Proc Natl Acad Sci USA, 1975,72 ( 9 ) : 3666 - 5670.
